Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly launches Phase I trial of investigational COVID-19 antibody treatment

europeanpharmaceuticalreviewJune 05, 2020

Tag: Eli Lilly , LY-CoV555 , COVID-19 , antibody

PharmaSources Customer Service